NCT00596999View on ClinicalTrials.gov

A Single-arm Safety Study of Transplantation Using Umbilical Cord Blood and Human Placental-derived Stem Cells From Partially Matched Related Donors in Persons With Certain Malignant Blood Diseases and Non-malignant Disorders

UnknownOBSERVATIONAL
Enrollment

6

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

July 31, 2013

Study Completion Date

December 31, 2013

Conditions
Hematologic Malignancies
Interventions
PROCEDURE

UCB and HPDSC

single dose of UCB followed by one unit of HPDSC

Trial Locations (1)

70118

Louisiana State University Children's Hospital, New Orleans

Sponsors
All Listed Sponsors
lead

Celgene Corporation

INDUSTRY